MTHFR and neoplasm: In tumor tissue, 5-methyltetrahydrofolate is required for optimal fluoropyrimidine efficacy, so that tumors with mutated MTHFR should be more sensitive to 5-fluorouracil (5FU) than wild-type tumors.